Vaccinia complications and methisazone therapy [2]

Clinical Infectious Diseases

Volumn 42, Issue 11, 2006, Pages 1653-

  McLean, Donald M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

METISAZONE; VACCINIA ANTIBODY;

ADULT; CHILD; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG RESPONSE; ECZEMA; FEVER; HUMAN; LETTER; PRIORITY JOURNAL; REMISSION; SUSPENSION; TABLET; VACCINIA; VOMITING;

ADULT; ANTIVIRAL AGENTS; CHILD; HUMANS; METHISAZONE; SUSPENSIONS; TABLETS; VACCINIA;

EID: 33646737887     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/504081     Document Type: Letter

References (3)

1. Nalca A, Rimoin AW, Bavari S, Witehouse CA. Reemergence of monkeypox: prevalence, diagnostics and countermeasures. Clin Infect Dis 2005;41:1765-71.
2. McLean DM. Methisazone therapy in vaccinia complications. Ann N Y Acad Sci 1977;284: 118-21.
3. Lewis FM, Chernak E, Goldman E, et al. Ocular vaccinia infection in laboratory worker, Philadelphia, 2004. Emerg Infect Dis 2006; 12:134-7.